| scholarly article | Q13442814 |
| P2093 | author name string | Jianfa Li | |
| Mingwei Chen | |||
| Chengle Zhuang | |||
| Zhiming Cai | |||
| P2860 | cites work | Crosstalk between transforming growth factor-β signaling pathway and long non-coding RNAs in cancer | Q38636275 |
| Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer | Q38782920 | ||
| LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p | Q38812739 | ||
| A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel | Q38838226 | ||
| CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling | Q38894596 | ||
| Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer | Q38899341 | ||
| lncRNA directs cooperative epigenetic regulation downstream of chemokine signals | Q38938483 | ||
| International variations in bladder cancer incidence and mortality. | Q38940493 | ||
| The Arabidopsis ABHD11 Mutant Accumulates Polar Lipids in Leaves as a Consequence of Absent Acylhydrolase Activity. | Q40294828 | ||
| Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo | Q45303836 | ||
| Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin | Q45353493 | ||
| The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation | Q61645724 | ||
| Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma | Q84148867 | ||
| Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer | Q85913930 | ||
| Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma | Q87622177 | ||
| Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance | Q88195492 | ||
| Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins | Q28118536 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| A long noncoding RNA mediates both activation and repression of immune response genes | Q28509769 | ||
| A micropeptide encoded by a putative long noncoding RNA regulates muscle performance | Q28513835 | ||
| A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle | Q28588509 | ||
| MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer | Q29617772 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer | Q30459452 | ||
| High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression | Q33514114 | ||
| PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer | Q33565650 | ||
| Long noncoding RNAs usher in a new era in the biology of enhancers | Q33938960 | ||
| The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. | Q34043853 | ||
| Decoding the function of nuclear long non-coding RNAs | Q34047824 | ||
| The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells | Q34619182 | ||
| Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. | Q35154104 | ||
| Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner | Q35238513 | ||
| RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. | Q35597360 | ||
| Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance | Q35735937 | ||
| Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway | Q35781460 | ||
| The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. | Q35793635 | ||
| Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer | Q35832173 | ||
| The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. | Q36356007 | ||
| The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. | Q36544646 | ||
| Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells | Q36562321 | ||
| shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells | Q37301723 | ||
| Urinary biomarkers of bladder cancer: an update and future perspectives | Q38138607 | ||
| Long noncoding RNAs: novel insights into gastric cancer. | Q38274777 | ||
| Long noncoding RNAs: novel players in colorectal cancer | Q38371277 | ||
| Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma | Q38568591 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bladder cancer | Q504775 |
| P304 | page(s) | 28176-28186 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer | |
| P478 | volume | 8 |
| Q64101604 | A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma |
| Q92713805 | A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis |
| Q55121977 | Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review. |
| Q92682386 | Decreased Expression of Long Non-Coding RNA GMDS Divergent Transcript (GMDS-DT) is a Potential Biomarker for Poor Prognosis of Hepatocellular Carcinoma |
| Q96133095 | LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis |
| Q58704141 | Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring |
| Q88810263 | LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1 |
| Q57483955 | LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis |
| Q92029419 | LncRNAs act as prognostic biomarkers in bladder carcinoma: A meta-analysis |
| Q60301983 | Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis |
| Q93036308 | Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA |
| Q49587675 | Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer. |
| Q55032248 | Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. |
Search more.